In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Erbumine, Perindopril Drug Master File in Korea (Erbumine, Perindopril KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Erbumine, Perindopril. The MFDS reviews the Erbumine, Perindopril KDMF as part of the drug registration process and uses the information provided in the Erbumine, Perindopril KDMF to evaluate the safety and efficacy of the drug.
After submitting a Erbumine, Perindopril KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Erbumine, Perindopril API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Erbumine, Perindopril suppliers with KDMF on PharmaCompass.